mizoribine has been researched along with concanavalin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XM; Endo, T; Inoue, K; Kamata, K; Kaneko, Y; Mizukoshi, M; Okubo, M; Sato, N; Uchida, H | 1 |
| Ando, Y; Beck, Y; Degawa, H; Ichikawa, N; Ito, S; Kikuchi, K; Meigata, K; Nagao, T; Nomura, Y; Tomikawa, S; Uchida, H; Watanabe, K | 1 |
2 other study(ies) available for mizoribine and concanavalin a
| Article | Year |
|---|---|
Decreased interleukin 2 production and increased LEU 2a-positive suppressor cells in renal transplant patients on triple therapy with mizoribine, cyclosporine A, and prednisolone.
Topics: Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Concanavalin A; Cyclosporins; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Interleukin-2; Kidney Transplantation; Prednisolone; Ribonucleosides; T-Lymphocytes, Regulatory; Transplantation Immunology | 1987 |
Immunosuppressive effects of bactobolamine in vitro and in vivo.
Topics: Animals; Benzopyrans; Cell Line; Cells, Cultured; Concanavalin A; Dogs; Drug Therapy, Combination; Female; Graft Survival; Immunosuppressive Agents; Interleukin-2; Kidney Transplantation; Liver Transplantation; Lymphocyte Activation; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Time Factors; Transplantation, Homologous | 1996 |